New Therapies for HIV-1-Associated Neurocognitive Disorder (HAND): Animal Models and Gene Delivery of Antioxidant Enzymes by rSV40
Book:
Frontiers in CNS Drug Discovery
Page:
80-117
Author(s):
Jean-Pierre Louboutin and David S. Strayer
Manipulation of Endogenous Neural Stem Cells as a Therapeutic Strategy for Neurodegenerative Diseases: Insights from Animal Models
Book:
Frontiers in CNS Drug Discovery
Page:
43-79
Author(s):
Anna Patten, Patricia S. Brocardo and Joana M. Gil-Mohapel
Epigenetic Modifications as Novel Targets for Drug Addiction
Book:
Frontiers in CNS Drug Discovery
Page:
26-42
Author(s):
Candace R. Lewis and Michael F. Olive
Developing Treatments for Prion Diseases and Implications for Other Protein Misfolding Disorders
Book:
Frontiers in CNS Drug Discovery
Page:
3-25
Author(s):
Brian S. Appleby
List of Contributors
Book:
Frontiers in CNS Drug Discovery
Page:
v-vii
Author(s):
Atta-ur-Rahman
Preface
Book:
Frontiers in CNS Drug Discovery
Page:
i-iv
Author(s):
Atta-ur-Rahman
Index
Book:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Page:
283-294
Author(s):
Atta-ur-Rahman
Pharmacological Treatments, Related Clinical Characteristics and Brain Function in Adolescent Depression
Book:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Page:
271-282
Author(s):
Kunio Yui
Current Pharmacologic Treatments in Impaired Social Interaction in Autism Spectrum Disorders
Book:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Page:
253-270
Author(s):
Kunio Yui
Pharmacological Treatment of Cognitive Impairment in Schizophrenia: A Critical Review of the Clinical Effects of Current and Developing Drugs
Book:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Page:
230-252
Author(s):
Seiya Miyamoto